Skip to main content

MSF.org

English
العربية
Español
Français

MSF medical guidelines

MSF medical guidelines

Main navigation

Home
Guidelines
Updates
Order
About
Favorites
Contact

All guidelines

Tuberculosis

Essential drugs

English العربية Spanish French

Clinical guidelines - Diagnosis and treatment manual

English العربية Spanish French

Essential obstetric and newborn care

English العربية French

Management of A CHOLERA EPIDEMIC

English French

Management of A MEASLES EPIDEMIC

English French

Tuberculosis

English French

Public health engineering

English French

Authors/Contributors
Introduction
Abbreviations and acronyms
Chapter 1: Introduction and epidemiology
Chapter 2: Clinical presentation
Chapter 3: Diagnosis and follow-up investigations
Chapter 4: Diagnostic algorithms for pulmonary tuberculosis (PTB) in adults and adolescents
Chapter 5: Diagnosis of active tuberculosis in children
Chapter 6: Intensive case finding in HIV-infected individuals
Chapter 7: Case definitions for registration
Chapter 8: Tuberculosis drugs and treatment regimens
Chapter 9: Treatment of drug-susceptible tuberculosis
Chapter 10: Treatment of multidrug-resistant and rifampicin-resistant tuberculosis
Chapter 11: Treatment of mono- and poly-drug resistant tuberculosis (PDR-TB)
- 11.1 Treatment schemes
- 11.2 Treatment algorithms for PDR-TB
Chapter 12: Tuberculosis and HIV co-infection
Chapter 13: Adherence to tuberculosis treatment
Chapter 14: Tuberculosis infection control
Chapter 15: Follow-up of staff exposed to tuberculosis
Chapter 16: Treatment of latent tuberculosis infection
Chapter 17: Monitoring and evaluation
Appendices

Breadcrumb

Home
Tuberculosis

Chapter 11: Treatment of mono- and poly-drug resistant tuberculosis (PDR-TB)

Select language:

English

(Arabic) العربية

Español (Spanish)

Français (French)

On this page

11.1 Treatment schemes
11.2 Treatment algorithms for PDR-TB

Book traversal links for Chapter 11: Treatment of mono- and poly-drug resistant tuberculosis (PDR-TB)

10.11 Treatment failure and palliative care
11.1 Treatment schemes

Send feedback about this page or ask a general question

Name

Email

Your message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MSF medical guidelines

MSF medical guidelines

© Médecins Sans Frontières 2023

Footer

Disclaimer
Cookie Policy
Privacy Notice